Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03741881 · ClinicalTrials.gov registry record
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)
A clinical trial, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- 231
- Enrollment target
NCT03741881 is a clinical trial that has completed, run by Novo Nordisk A/S. The registered enrollment target is 231 participants.
The verdict
NCT03741881 has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- 231 participants
- Enrollment target
Study Summary
This study will collect data on bleeds and data related to quality of life in people with severe congenital (a disease existing from birth) haemophilia A and B, with or without inhibitors. The aim for the study is to look at the number of bleeds when on usual treatment for haemophilia. Participants will be asked to keep an electronic diary to track the number of bleeds and the treatment of their bleeds. Participants will be asked to wear an activity tracker on their wrist to capture their level of activity every day for up to 12 weeks. While taking part in this study, participants will keep getting their usual treatment as given to them by their doctor. All study visits at the clinic are done in the same way as the participants are used to. In the time between the participants' visits to the clinic, the study staff at the clinic may call or email the participant. The study will last for about 2½ years.
Interventions
- OTHER No treatment given
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 231 participants |
| Start Date | 2018-12-18 |
| Est. Completion | 2021-10-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03741881
The ClinicalTrials.gov registry entry for NCT03741881 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 231 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novo Nordisk A/S, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No treatment given is the first listed.
NCT03741881 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03741881 about?
NCT03741881 is a clinical study titled "A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)". This study will collect data on bleeds and data related to quality of life in people with severe congenital (a disease existing from birth) haemophilia A and B, with or without inhibitors. The aim for the study is to look at the number of bleeds when on usual treatment for haemophilia. Participants ...
What is the current status of trial NCT03741881?
This trial is currently completed. The enrollment target is 231 participants. The study started on 2018-12-18. Estimated completion is 2021-10-25.
What interventions are being tested in trial NCT03741881?
The interventions under investigation include: No treatment given (OTHER).
Who is sponsoring clinical trial NCT03741881?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.